Ikarian Capital, LLC Sangamo Therapeutics, Inc Transaction History
Ikarian Capital, LLC
- $328 Million
- Q2 2025
A detailed history of Ikarian Capital, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Ikarian Capital, LLC holds 1,260,179 shares of SGMO stock, worth $655,293. This represents 0.21% of its overall portfolio holdings.
Number of Shares
1,260,179
Previous 1,860,179
32.25%
Holding current value
$655,293
Previous $1.23 Million
44.58%
% of portfolio
0.21%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding SGMO
# of Institutions
126Shares Held
50.6MCall Options Held
1.13MPut Options Held
820K-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.87 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.08MShares$4.2 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$3.56 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.45 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$1.21 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $81.4M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...